‘European cannabis is hard, hopeful, and constantly in motion — adult-use pilots, a maturing medical market…’
Speaking on From Plant to Patient: Why Genetics Must Lead Medical Cannabis Outcomes
Adele Hollmann is a cannabis scientist and educator working to bridge science, policy, and culture in the emerging era of plant medicine. She holds a Master of Horticultural Science and is a certified Cannabis Sommelier, combining deep expertise in plant biology and cultivation with a refined understanding of cultivar quality, sensory profile, and chemovar diversity.
Based in Germany and working with Sanity Group, she focuses on how evidence-based regulation, well-designed products, and honest education can deliver better outcomes for patients and consumers across Europe. Her work moves between science, public education, and policy advocacy within adult-use pilot projects.
Adele is a vocal advocate for responsible plant medicine and for ending the stigma that still shapes how cannabis is discussed, prescribed, and policed.
On the London 2026 programme
- Day 2 · Main Stage · 9:30 amFrom Plant to Patient: Why Genetics Must Lead Medical Cannabis Outcomes